Table 1.
Variable | HIV Infected, Case, n = 6816 | Non–HIV Infected, Control, n = 6816 |
---|---|---|
Gender, N (%) | ||
Female | 2953 (21.7) | 2940 (21.6) |
Male | 3863 (28.3) | 3876 (28.4) |
Race, N (%) | ||
Black | 4856 (35.6) | 4786 (35.1) |
Others | 560 (4.1) | 587 (4.3) |
White | 1400 (10.3) | 1443 (10.6) |
Age categories, N (%) | ||
18–29 years | 186 (1.4) | 187 (1.4) |
30–44 years | 4705 (34.5) | 4638 (34.0) |
45–64 years | 1857 (13.6) | 1905 (14.0) |
≥65 years | 68 (0.5) | 86 (0.6) |
Median age at study entry, y (IQR) | 38 (31–46 ) | 38 (30–46) |
Median months enrolled (IQR) | 53 (22–106) | 50 (23–103) |
Baseline hypertension, yes, N (%) | 921 (6.8) | 973 (7.1) |
Baseline diabetes, yes, N (%) | 387 (2.8) | 377 (2.8) |
Baseline dyslipidemia, yes, N (%) | 192 (1.4) | 208 (1.5) |
Obesity, yes, N (%) | 666 (9.8) | 674 (9.9) |
Comorbid hepatitis B, yes, N (%) | 431 (3.2) | 46 (0.3)a |
Comorbid hepatitis C, yes, N (%) | 927 (6.8) | 187 (1.4)a |
Documented tobacco use, yes, N (%) | 1994 (14.6) | 2100 (15.4)b |
Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range.
Significant at P ≤ 0.001.
Significant at P ≤ 0.05.